Inventor
SCHAAPVELD ROELAND QUIRINUS JOZEF
NL9 patents
⚠️ This page may combine multiple inventors who share the name “SCHAAPVELD ROELAND QUIRINUS JOZEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTERNA TECH B V
6 patentsUS10023868B2Jul 17, 2018
MiRNA for treating diseases and conditions associated with neo-angiogenesis
INTERNA TECH B V3 citations65
US9944932B2Apr 17, 2018
MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT
INTERNA TECH B V2 citations65
US10201556B2Feb 12, 2019
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
INTERNA TECH B V4 citations63
US11497762B2Nov 15, 2022
MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
INTERNA TECH B V0 citations45
US10583149B2Mar 10, 2020
MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
INTERNA TECH B V0 citations43
US10174314B2Jan 8, 2019
MiRNA for treating head and neck cancer
INTERNA TECH B V0 citations26
INT TECH B V
2 patentsUS9682095B2Jun 20, 2017
MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
INT TECH B V3 citations63
US9441222B2Sep 13, 2016
MiRNA for treating diseases and conditions associated with neo-angiogenesis
INT TECH B V3 citations62